FilingIndex
← The Wire
CVKDNasdaq

Cadrenal Therapeutics, Inc.

Pharmaceutical Preparations · DE · CIK 1937993

Advancing novel therapies for life-threatening immune and thrombotic conditions, focusing on CAD-1005 for HIT

red 8-K · 90d
$11M
Market cap
$3.02
Last close
-1.0%
1D
-5.0%
5D
33K
Volume
Price · last 39 sessions-54.3%
May 4L $2.86 · H $6.61Jun 29
98
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end

Insider Activity

In the 90 days to Dec 29, 2025: 2 sold $298K.

DateInsiderActionSharesPriceValue
Dec 29, 2025Szot Matthew KChief Financial OfficerSell9,933$6.97$69K
Oct 27, 2025Szot Matthew KChief Financial OfficerSell1,800$13.99$25K
Oct 27, 2025Pham Quang XCEO and ChairmanSell1,315$13.99$18K
Oct 24, 2025Szot Matthew KChief Financial OfficerSell1,800$13.99$25K
Oct 24, 2025Pham Quang XCEO and ChairmanSell1,129$14.03$16K
Oct 13, 2025Pham Quang XCEO and ChairmanSell1,800$14.15$25K
Oct 13, 2025Szot Matthew KChief Financial OfficerSell1,800$14.07$25K
Oct 9, 2025Pham Quang XCEO and ChairmanSell1,800$14.02$25K
Oct 9, 2025Szot Matthew KChief Financial OfficerSell1,693$13.99$24K
Oct 6, 2025Szot Matthew KChief Financial OfficerSell107$13.99$1K
Oct 2, 2025Pham Quang XCEO and ChairmanSell500$14.13$7K
Oct 1, 2025Szot Matthew KChief Financial OfficerSell1,700$13.99$24K
Oct 1, 2025Pham Quang XCEO and ChairmanSell881$14.01$12K
Sep 29, 2025Pham Quang XCEO and ChairmanSell419$14.01$6K
Sep 29, 2025Szot Matthew KChief Financial OfficerSell100$14.00$1K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance